Google TrendMICHAEL OLISE (500+) — Transfer Rumors: Liverpool Handed Olise Boost; Man Utd Battle Real Madrid for McTominay
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "New precision GLP-1 agoni" (30 stories)

Top Headline Story

Genetic predictors of GLP1 receptor agonist weight loss and side effects
Lead StoryNaturegeneral
Apr 8

Genetic predictors of GLP1 receptor agonist weight loss and side effects

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9IUFh1U2pjNEx4RVVDZmxGRWQ4NTZRS2NoVGFGa2NqeWNWZmJZd3NQOXAyMk84NlY2aTh6d0d6Y1F6V1d5a1RibFRMYlpNNER2R3BqMTNYNGJXSHozZ0w0?oc=5" target="_blank">Genetic predictors of GLP1 receptor agonist weight loss and side effects</a>  <font color="#6f6f6f">Nature</font>

Real-time search volume
500+18m ago

michael olise

Transfer Rumors: Liverpool Handed Olise Boost; Man Utd Battle Real Madrid for McTominay

1000+18m ago

bank of america fine

Bank of America fined $1.2 billion over money-laundering violations

200+18m ago

club brugge

LIVE: Dan toch 1-1! Club laat zich na penalty Tresoldi te makkelijk vangen, Lautaro zorgt voor gelijkmaker

200+18m ago

rb leipzig

Nach 6:0 in der Liga: Demichelis erwartet anderes Kaliber

Search Results for "New precision GLP-1 agoni"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
New precision GLP-1 agonist could reduce side effects in patients
Drug Target Reviewgeneral

New precision GLP-1 agonist could reduce side effects in patients

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxQcHY1MnZ4Si10Q09Fd29JbDU3NmI5MkhPcGhCVV9xbVQ4WWF2TjRPUnB3cWhXZkdXcktYZUd1T0ExVHJUNVR0enRUSnRaZVJlODBRbzg2THpNQXhpdDZHSGxyVmNoRnQzVG0xYkQtRnR3cXF0dmJRSmFtV3l0QUdQam0weVZscDlNSVB6UmpGZFBvRzVhNktVczVhOHhMZ2hsU2RJZEw2UHFDWnVDOVRVVFdwN1A?oc=5" target="_blank">New precision GLP-1 agonist could reduce side effects in patients</a>  <font color="#6f6f6f">Drug Target Review</font>

Triple Agonist Retatrutide Pushes Weight Loss to New Levels in Type 2 Diabetes
Inside Precision Medicinegeneral

Triple Agonist Retatrutide Pushes Weight Loss to New Levels in Type 2 Diabetes

<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxQLUJuMzd3b29uYVQ2cW9Ga1NSZkZEWXBtdmNIQUd0VHNlS0J1cHBvUDdUaWc0Wk9pVmJuMXNLX0xVVXFvMk9tODU3d09yTnhWaDMxZ1VCdXBqSmVtWjhhZUhrTTlsTkY2RGJoaHYwVmxXc0k5YnpGclQ5OTZtM0ozaGpRSnlTMkJrUUNGVXc3Q0sxd0lpTFNma2pGTi1VZVZ3dll4dFpRNDRVNWhRVEhQaGlBdko1bzBvTVVTMWZHWnFLTHZTaGhRY3h5RE5NQy1Va0oxOG9qaUxkMDJpTnc?oc=5" target="_blank">Triple Agonist Retatrutide Pushes Weight Loss to New Levels in Type 2 Diabetes</a>  <font color="#6f6f6f">Inside Precision Medicine</font>

How precision nutrition may enhance effectiveness of GLP-1 drugs
Medical Xpressgeneral

How precision nutrition may enhance effectiveness of GLP-1 drugs

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxObnlud1VqWGRjVjBObnBRbUo5UWFkWHY2OVFJLTY5WjUtbEZaeFVxUEZKWVViUkxyUUZZTkRtVWRMQjEtcXMyV04xTnlKek9oT1lLak1haEVXSk12VFFyRjZQSi1sMXhTZ0VqdWFEdW53OUoxalRRbG9sWlBVT0pIaGdlLTZqamNRRlpKNW1WdE0?oc=5" target="_blank">How precision nutrition may enhance effectiveness of GLP-1 drugs</a>  <font color="#6f6f6f">Medical Xpress</font>

Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial
Eli Lillygeneral

Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxON3NVckJMRldHbWRFSGlabUtDcEdycEd2MkxmUGlSc2dfcWhkWlQ3aDZ3QUlBeS11akFzMU40QjE1VzdwZE1hU2RoTWlxdVlYdmd0b2x4Yk4tcXR6SWNRZnFqa1dlU2haOFp5NkJWRjFSQXVVdmJYUzlMS3FtT3RDSFU4cmtlSkhXLUZtQkMzQ2M1cXF1RzJjRXFDc1lfOWw3ZnRjblVlc0UzRVRzeV93NDV6dERqWDJMaEN5V1hOMXZheHc2?oc=5" target="_blank">Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial</a>  <font color="#6f6f6f">Eli Lilly</font>

EX-99.1
SEC.govgeneral

EX-99.1

<a href="https://news.google.com/rss/articles/CBMiiAFBVV95cUxNN2hycjJrUkwxcHJBeU5aeHhFOUU4TUZHcmMzWlp3RVFIUTBybmpXa0pFakRvYVl4X2d4dkJhdVFqcTN6U0ZEdWV5VWRuXzBiT3BuNXlwTjMwaExNRzVuMTN3Q3d2SUFMZ2hNc3VkX3U3SmJBT3NRdGlwVGVhLXA5Wl9PSDBrVWpx?oc=5" target="_blank">EX-99.1</a>  <font color="#6f6f6f">SEC.gov</font>

Combining GLP-1 and SGLT2 Drugs Produce Some Benefits in T2D
Medscapegeneral

Combining GLP-1 and SGLT2 Drugs Produce Some Benefits in T2D

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPMHhjUzJWNjZvR2tCOEhRTmhtZ28xN1NsR1JCUVdvWmROYWVGRmFsX2xwelpIT0xPdzJZRDExU0k4b1dRZkt4Z19ZeGpEenJYTy1PaXJ4NTM2dUo1TUJNeFRlc3NWVzJfU1d1ajZvZi16eFY3ZzBLbE91dzM3dUNJaTRNR3QtU0dTbXhsWDNsRXRkQ1RIQnlPa0dkSUNsbzFaT0ROak50amhjRG8?oc=5" target="_blank">Combining GLP-1 and SGLT2 Drugs Produce Some Benefits in T2D</a>  <font color="#6f6f6f">Medscape</font>

GLP-1 Treated Patients with Diabetes Have Raised Risk for Eye Condition
Inside Precision Medicinetech

GLP-1 Treated Patients with Diabetes Have Raised Risk for Eye Condition

<a href="https://news.google.com/rss/articles/CBMi2gFBVV95cUxOZGRkS3JEQ3VPYlpxV0JmSEtpU0kyaDhiN1BUazdBR2hKc0VXVF94clppallrNElWYVVZR3VQblhFSUdFRU1lbDlIZWNORjhNUHRaalg5em9TbURZbGwtQzdtRV8tUlE4TEh1SGlDZm5uZjRSNFRaa1FKSnVNaXV0WXNZWlZHU29UZzc5V21hLWdWQjRpNWltREgyeXhlTi1wUFNrb3F6M3ptV3JFdC1DVlMydlNnWl9lZ0dQQTZ2LW1KcHJ1ZUszODRwSG8wQlN2QXlFYnhVQkZQQQ?oc=5" target="_blank">GLP-1 Treated Patients with Diabetes Have Raised Risk for Eye Condition</a>  <font color="#6f6f6f">Inside Precision Medicine</font>

Amid obesity push, Pfizer strikes deal worth up to $495M to market Sciwind's approved GLP-1 in China
Fierce Pharmamarkets

Amid obesity push, Pfizer strikes deal worth up to $495M to market Sciwind's approved GLP-1 in China

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxQeUJraXdwWFk5blItSy1EWjFpVkR6d0Y0R3BJV3pGS29pMXN5RkhIYVA2U2NXV3FjaDBEZXNYR2FPTTNCbzhNbXhRdEhqWU5jWXZVckNEVW1TYnBueXlxdFZwcHFNZm1vN2g1VjZSTnhNZV9mZUZQSGYzWkpvOGwzRnVhODg2VEpnQ0JIQ1hRQmtqRG8ybnpPSWtSZnkyV2hpbUpxUzREazdjRHp3UTdRZGtkQ1g5dFROZHVRbmtn?oc=5" target="_blank">Amid obesity push, Pfizer strikes deal worth up to $495M to market Sciwind's approved GLP-1 in China</a>  <font color="#6f6f6f">Fierce Pharma</font>

Kariya and NeuraLight Partner to Measure How Next-Generation GLP-1 Therapies Impact the Brain
BioSpacetech

Kariya and NeuraLight Partner to Measure How Next-Generation GLP-1 Therapies Impact the Brain

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxNNFlVNmsxQndqN1F3RUdycTNYWmxhcUh0QkRTa0ZnbjVXOEZodUN1TlB5TDRoTEp4c1kwbTF2d1EtNHJZTGJQbjBiS01GVFg0MnpaQlBsSWs0MlB6MHV6U25RckFUMzlqckxnUy1hZUZSeFAzZ2hCc3BSZV9YZ0tpQ2U2N3hLMFJKX013QjNyVVhuR09oX3ZjSkR4VHF3WFhtNzV5VkMwTElVWXJEMmZ1Mk9MUEdBd0tmT0pON3FSSW56a29ueDlzZ3gyMWl3QQ?oc=5" target="_blank">Kariya and NeuraLight Partner to Measure How Next-Generation GLP-1 Therapies Impact the Brain</a>  <font color="#6f6f6f">BioSpace</font>

The New Era of Pharma Distribution: Balancing Precision and Scale
Pharmaceutical Commercegeneral

The New Era of Pharma Distribution: Balancing Precision and Scale

<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOak5qVGZKQTllWXBQa3BDc04zWS1Edy1ibkxBVFZSU2JuS3RYR2lWLUY4cEFONDNZVnppdi1iNDlySEpJOHFQV3BKc3lkbUFHUDdIOXJfalhoQjV2dFVwTnpWdHotaXY3UmtLZlZzQ2ZGYXJRZ29sREI3dEJCLVVSbl96WjJXencwQ0hKbHp4Tm1uY0RCYVpibEpfZVdJc2NFNmRrM0hJWkluTWhu?oc=5" target="_blank">The New Era of Pharma Distribution: Balancing Precision and Scale</a>  <font color="#6f6f6f">Pharmaceutical Commerce</font>

Study reveals how GLP-1 drugs trigger weight loss in brain cells
Drug Target Reviewtech

Study reveals how GLP-1 drugs trigger weight loss in brain cells

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxOSm05bXN3Z0EzOW4xcnRYN1lQQnNCSFBYZDlSU05fZ1dxTXdheWlNUk5OVTNnQy1SaUJFVEpqWDZ4N2FkTHRlVGlVTGxSX1NzV2NqdGNXUGpaT0NRamIwLUN3dWtRU2FYY3hLSnNXanFJbmFXTE0tSFhMZmlYa2p4LTRyZldvZlkxOElyaUxlY2FjdVA3YUlNWi12MDhpcmRpRllqemt1bmNpcENsazJiQ2Zmaw?oc=5" target="_blank">Study reveals how GLP-1 drugs trigger weight loss in brain cells</a>  <font color="#6f6f6f">Drug Target Review</font>

GLP-1 agonist clinical pipeline 2026: semaglutide, tirzepatide, and what’s in Phase 2
Drug Discovery Newsgeneral

GLP-1 agonist clinical pipeline 2026: semaglutide, tirzepatide, and what’s in Phase 2

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxPLWZwR2hwZTBjZlY0M1pIelZXcEI0RmFPVWRwbm1jZVhZY0p2X2NZeU1ZSGpwUENQQlBCbElxbWc3NjJ0TzRleUFZbUwzTjVraXNkZFVrc3FOREcxUE5sY0pPeU1PNDgyTGdua1hQV2NRQXZJYWczZHZBODJHLWFWanJmOV85UXRxTDNpaUlfSENkd08yQkQtY0sybm5taHJPdWc1VG1wWWZsbFhRNlVSem1WLUtQVGN2QnVzOUlBOA?oc=5" target="_blank">GLP-1 agonist clinical pipeline 2026: semaglutide, tirzepatide, and what’s in Phase 2</a>  <font color="#6f6f6f">Drug Discovery News</font>

Pfizer breaks into obesity market in China with approval for Sciwind-partnered GLP-1
Fierce Pharmamarkets

Pfizer breaks into obesity market in China with approval for Sciwind-partnered GLP-1

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQX3lCR0hiRU84bWlmTjI4dDY0dWVqeUNIc01jaVRCbUJsc0ZkME45UVFCcGYtUXVLMktUd1JnV2hXNXZmSC1pMXN0TVh3cWxOaFhaS0Nva2NSS3dxV183Ykw5bjF1YXVWNmJPTGNPcWhsaTdrZWtvRE1wUEpqTW13TUVOcWFvYks5amR3R01HVTZITzBfcGdRbTVLeWxibnIxRy1Db0tR?oc=5" target="_blank">Pfizer breaks into obesity market in China with approval for Sciwind-partnered GLP-1</a>  <font color="#6f6f6f">Fierce Pharma</font>

First Clinical Trial for a GLP-1 Gene Therapy Greenlit in Europe
Inside Precision Medicineworld

First Clinical Trial for a GLP-1 Gene Therapy Greenlit in Europe

<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxOakxnOWtvdnoyWW5jbXNNbUMzZXdDdm4tNUJCNlVMeFotc19UdFQya1dpeHZVUXdiMmNMa3J6WXBYdnJyaUlfR0FGWDNEaTN4V1U4WklkZ21palB5MU5vdkZGMDdXNHZCNnlEUXdNVTEzUTVjVEZtcVcwZUw4c3ZxcHp6cTJTQVZZVGI1Q0tjQTJVRFpRcjFVNkpkZGlIbHZsb2RsbTY2TTFuR09iWXJaQmRsR1JlUUpQMlhnTFZJM2x6TXc3SVRRX1J6REYyWFho?oc=5" target="_blank">First Clinical Trial for a GLP-1 Gene Therapy Greenlit in Europe</a>  <font color="#6f6f6f">Inside Precision Medicine</font>

Designing GLP-1 delivery: structural perspectives and formulation approaches for optimized therapy
Naturegeneral

Designing GLP-1 delivery: structural perspectives and formulation approaches for optimized therapy

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1TRFhqOTg4eVhaYVdnejkwTVpaRkl1QTJjd0dRMHN3R29ST2dzdkdjNG9BdU1xdDRPMXotc1l5QW03RHVaVE0takhCQmJEMnJfem1pcnlVSWR3S0Z1TjI0?oc=5" target="_blank">Designing GLP-1 delivery: structural perspectives and formulation approaches for optimized therapy</a>  <font color="#6f6f6f">Nature</font>

Genetic Biomarkers to Predict Efficacy of GLP-1 Therapies Uncovered
Inside Precision Medicineworld

Genetic Biomarkers to Predict Efficacy of GLP-1 Therapies Uncovered

<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxPZm92dHNvSzhKV3hwVkJLT3FYZjhZbkpIdzltT1NjRWpSdkdUSkZVUWd5ekNpN1VPekN0ZVduaHZFbmF0QjJfSFkzdGQtNzUzYlNLaDFJaGZDREdrSF9EN0UtUVFELUdUR0pKUFgzZzN0UGtFQ3prTWNmZ0tHYmxzeFplUGp1ZUZoREZKVDh1dll0OGJ6bTh5Y1ViOS1vMDhGOFRQYVJac1JDdzh6WGNxQzduTEExcDhXQlhBbjVxd0VGZkRjOFpzVU55bGdPM0E?oc=5" target="_blank">Genetic Biomarkers to Predict Efficacy of GLP-1 Therapies Uncovered</a>  <font color="#6f6f6f">Inside Precision Medicine</font>

GLP-1 Receptor Agonists Have Minimal Impact on Obesity-Related Cancer Risk
Inside Precision Medicinegeneral

GLP-1 Receptor Agonists Have Minimal Impact on Obesity-Related Cancer Risk

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxOZ3pzaEY4Z3VVaFdvNW1IU0ZyOExSdXhaeW9LczdIYWNUOWdranNQMVAxeUdpTEMwVVlXdEFrb0JEcHR0dEpVa1AzLWVkSWhmM0toM1MzYkROa24tMmtjY0ZPQ2lKVHpPalloSW1CMzR6M2d1STVMejJBSUR0ZkNuZy1jLWVrZkY4UUR6c2lmbndhUkFqZEtrOUc1aWRkTVhXYkV4WWxFTTB5MmZNWXJQQXh2eHJPaHozVktZSUhZU0Z5ckJpTkRNcjNIWQ?oc=5" target="_blank">GLP-1 Receptor Agonists Have Minimal Impact on Obesity-Related Cancer Risk</a>  <font color="#6f6f6f">Inside Precision Medicine</font>

GLP-1 Agonists May Protect Against Bone Fracture Risk
Inside Precision Medicinetech

GLP-1 Agonists May Protect Against Bone Fracture Risk

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNLXFiZFB5d0pldXFDNlhjRjBmdmdrNXBzTkZiWE9zMko0XzB4SkhqaHo4WlRmZHZ2RVFXMmxIX2hMNVQyeFJWVnFUUHdGOVhDdlVpaktxSVVuX1Fyazk1a2E1MmRTbHdvY2x4NU8tZ0EtS0wxRXRscjY3Qy1ZX1F5VXVwaGdQa0lhYTdvaVo1YTNzWGxlZ2ZjQ2QtU2Q1WE82cW1TcmRid240NGhqaUhQak9qUTQ?oc=5" target="_blank">GLP-1 Agonists May Protect Against Bone Fracture Risk</a>  <font color="#6f6f6f">Inside Precision Medicine</font>

Novo Nordisk’s GLP-1 Drug Fails to Improve Alzheimer’s Symptoms
Inside Precision Medicinetech

Novo Nordisk’s GLP-1 Drug Fails to Improve Alzheimer’s Symptoms

<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxQanhHaFhMVnRaUDd3NVVRWkRvVU1ubTZrOHJTNS1sMFJST2FMVmtjRXNsTlIxejZrQlpIZ3ZtWGxYQXU0Y25BWVFCOGtlb3Q2dzNDdXd4dml6RXVLTnAtYzRYNEVTQjVjenBUSjVPOEZCRTRuNHo2Rms2dWdjMVR2UE4zb3hvOFI5QzZGUkxKZWRiV2x3UGJESmlvT0ltVEhBc1VyMmk0cUVuQS00bll0VEstVEdKcEZ2RnFGZXhmRQ?oc=5" target="_blank">Novo Nordisk’s GLP-1 Drug Fails to Improve Alzheimer’s Symptoms</a>  <font color="#6f6f6f">Inside Precision Medicine</font>

Novel Oral GLP-1 Shows A1c and Weight-Loss Benefits
Medscapegeneral

Novel Oral GLP-1 Shows A1c and Weight-Loss Benefits

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNR0ZTQm1qTTdzbkxtelU0M0NETEV5cXdqVmRuNGRvNzE5Q1l5T0ZaZEs1NWtuTWN3emU4QTF5QXh0WEctV3BJT3VURjdlMzRaaHY0M1lvSW8zYXA0UG54ZjJleVBJdlpsbk5xbUdNQVlxbEdNZ0paN3R0bFd0NWxqODljYUVMSUgtZV9ucFRLd2NSWUYzU0piZ1daZHhHTElubG40?oc=5" target="_blank">Novel Oral GLP-1 Shows A1c and Weight-Loss Benefits</a>  <font color="#6f6f6f">Medscape</font>

GLP-1 and health: Beyond weight loss in the Ozempic era
UC Davis Healthscience

GLP-1 and health: Beyond weight loss in the Ozempic era

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxQMDkyb3lZZFdyalItMzZMbWh2ajdfZGg3ODd6TTM0b3N1emFWWnRRVDR6UDBvbmlxSGVUZ3JnUVpEVEgyT2FBYnliX2tvQzJ0YzBJdjBRZi00Rk91MWVLOTh1Qm9HM056ZmhhNzRmYWhLZDBrbEFlWU9heE9OdWpsclFQNmNxRUd3MXVYcWlza3g5T0xaQmNfLWJCYXlXaC1ZbVpJbWJnb0kyOXZpUjBn?oc=5" target="_blank">GLP-1 and health: Beyond weight loss in the Ozempic era</a>  <font color="#6f6f6f">UC Davis Health</font>

GLP-1 drugs don't work for everyone. But personalized obesity care in the future might
NPRgeneral

GLP-1 drugs don't work for everyone. But personalized obesity care in the future might

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxPU3k1bWRiekdOLW1QVHZFN2x2ampUTkduWTVQOHpmZmtSOVBlMTlGWjl0QWRyZkx2TWFqbGlCaWh4T3BTZjA3aFlsdzR1Rl94MGNVRVh5SklWNVhyNThvVUlUOTByRDRUYlBVSzVtX0drTVUzS2dUeE9rX3UwVDRyNkpRQUFtSW9wSXRPUnViNl9oTmJLOU15c3JqYktmYklEcm1CVjZwb3g5cEpRN2lR?oc=5" target="_blank">GLP-1 drugs don't work for everyone. But personalized obesity care in the future might</a>  <font color="#6f6f6f">NPR</font>

GLP-1 Receptor Agonist Study Confirms Past Trials, Adds Benefits and Risks
Inside Precision Medicinegeneral

GLP-1 Receptor Agonist Study Confirms Past Trials, Adds Benefits and Risks

<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxPV0hMZGFJc1pPQVIzN3J5WGsydEdyRTVBNndaUFpVSTdXYUVHVUhiWDh5RUp6djkxQlVXTWxvMzN5N0stTllFemJ4Uk1qSmVXT0dzc0laXzU0VWZoSjFMMGFVbUNoUU5WdUxjV2VVcWdDVGQyNDFtOVlnYlVVYWxIQ3AzTWZSNEhiM0JQeFVPNEw4UmF6ejJua3ZGVUtibzF1NWdid3lUbTNKd0doX3ZOd2lBaFJkd0Z6SHk1V3RmRXBSSXh3SVJJNWItQXBOQQ?oc=5" target="_blank">GLP-1 Receptor Agonist Study Confirms Past Trials, Adds Benefits and Risks</a>  <font color="#6f6f6f">Inside Precision Medicine</font>

Visual demonstration of weight loss and health risk improvement with a dual GIP and GLP-1 receptor agonist
Naturescience

Visual demonstration of weight loss and health risk improvement with a dual GIP and GLP-1 receptor agonist

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5yTE1aaWYxNFBOUjBZam50YkkxY3JZVDMxZXpHa01zZzZCVTJUTGpvaGVkM203a0dsTF9FeWw3REFxX3RTVkRESWhPOGNmZWg0MklmRi1yLTVPZEhNNHln?oc=5" target="_blank">Visual demonstration of weight loss and health risk improvement with a dual GIP and GLP-1 receptor agonist</a>  <font color="#6f6f6f">Nature</font>

The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy | Scientific Reports
Naturegeneral

The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy | Scientific Reports

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9iUXRfVGdhT2VUa3Rkc1FONW5JdkZoWDREckU2bE1PQmVuNW5Tb0xDN3BsRVF2a1JoZHVya01TRWNCSDhVQW42TDIzQ0JMd18tTGI4NVd0NVdWTlYzbUhz?oc=5" target="_blank">The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy | Scientific Reports</a>  <font color="#6f6f6f">Nature</font>

GLP-1 Agonists May Alter Cancer Patients’ Scan Findings
Inside Precision Medicinegeneral

GLP-1 Agonists May Alter Cancer Patients’ Scan Findings

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxPU0R4S3ZqZklWTTJCUDZjcUF1UXpveXVLaVVPdWNpTHhNRnlsQlBCMC1wdmVoTXdGVHBSSnA2bjNxSEc4Y1kzQ21Qdms5ME9sWExZZmFKYU1ZTjdESTdLV01RU3R3UDR6N0NyWWQ1bVM2b1hPQkZ1RTQxZF9mRVBwTW5OVmVFUzVNdjAyWVAzdmJ6bEhPd1YyQlBMeGhhZ0FlaVRGZmY2ai1VQU40eW5oVQ?oc=5" target="_blank">GLP-1 Agonists May Alter Cancer Patients’ Scan Findings</a>  <font color="#6f6f6f">Inside Precision Medicine</font>

Novel GLP-1 Agonist Promotes Safe and Effective Weight Loss
Medscapegeneral

Novel GLP-1 Agonist Promotes Safe and Effective Weight Loss

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxPQ1VZQm9VNUFnOGdWN3F3ak5fbnlwR1ZBa2RMblJlTXd2cDNKdF9PdW4wczRWY0lPYUs2ZkJmVW1ZMDFCMEJWREMxNGZUZVBYUzhVTXJxUzF4aHJhUTcyUXU1eWticTdHX3diMGVaekZiTGUyVncxZmo2cnA3MDVWbkNFdnhjWFl6cEp0a1R0OGFEQ1AwOG5DQVluYTV5NTc2ckxOTXFDZ0c5SC1WeVE?oc=5" target="_blank">Novel GLP-1 Agonist Promotes Safe and Effective Weight Loss</a>  <font color="#6f6f6f">Medscape</font>

Beyond GLP-1: the next wave of weight-loss medication innovation
The Pharmaceutical Journalgeneral

Beyond GLP-1: the next wave of weight-loss medication innovation

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxNWGdfTmg2MmtSS0JZa3JGb2FOSGQ3dVRkZzRwS1VNbkl3VUV3ZzBkQkJyWThPeTZXc3VXUVQ3VVdaU0xMWnlvbHhabWpqT3RWdVIzVXpRbWJNNDJfUXpvR0RhOW9oTFdCcTNpZDBlblh5c21tMmkyc25KN29DcXJpY2thd2pMd3lWUFpGc18wcjQyZk5UejhHU09RLW5IZmxhWE9heUhzRW05cFNFcnNkek0wNWs?oc=5" target="_blank">Beyond GLP-1: the next wave of weight-loss medication innovation</a>  <font color="#6f6f6f">The Pharmaceutical Journal</font>

The ‘forever drug’ assumption about GLP-1s may be wrong, according to nference analysis
Drug Discovery & Developmentgeneral

The ‘forever drug’ assumption about GLP-1s may be wrong, according to nference analysis

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxQSlNNSmRmTUF2ZTU0N2lIcEJ3eGlmTWxaRlNuam9QOVJoTmU5NERER2RTa3J0bC1WVEw3eHhzaVlqVWZBcXJwUzl1UjE3TW5xU09ndXIwVWtLdGxYVzdXZHZ4eHB5OTladEg4M3V5MVk4eXhIbWZHT3c0R3E5dFhzc3lKWi0tSVViamZ5V1FFWUJjdlhGNWo1Z2UzaGMwMmtseTNUTVFzRXI2NkpYS3JBWEtVVk1MZm9CWVJFY1VR?oc=5" target="_blank">The ‘forever drug’ assumption about GLP-1s may be wrong, according to nference analysis</a>  <font color="#6f6f6f">Drug Discovery & Development</font>

"New precision GLP-1 agoni" — Live Google News Trends & Headlines